MYD88 and central nervous system cancer: reported that the activation of TLRs converts microglia into a glioma-supportive phenotype through upregulation of membrane type 1 matrix metalloprotease (MT1-MMP), depending on signaling via the TLR adaptor molecule MYD88 (19).